John Schafe
Vice President of Investor Relations
Replay available
GoHealth, Inc. (NASDAQ: GOCO) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations
Chief Executive Officer
Analyst, Stonegate
Analyst, Granite Research
Analyst, Noble Capital
Analyst, Sidori and Cole
Broker, Good Freedom
Good day and welcome to the Go Health Second Quarter 2025 earnings conference call. All participants will be in listen-only mode to prevent any background noise. After today's presentation, there will be an opportunity to ask questions. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. Please note this event is being recorded. I would now like to turn the conference call over to John Schafe, Vice President of Investor Relations. Please go ahead. Thank you and good morning. Welcome to Go Health Second Quarter 2025 results call. Joining me today are Vijay Kote, Chief Executive Officer, and Brendan Chanahan, Chief Financial Officer. Today's conference call contains forward-looking statements based on our current expectations. Numerous known and unknown risks and uncertainties may cause actual results to differ materially from those anticipated or projected in these statements. Many of the factors that will determine future results are beyond the company's ability to control or predict. You should not place undue reliance on any forward-looking statements, and the company undertakes no obligation to update or revise any of these statements, whether due to new information, future events, or otherwise. Earlier today, we issued a press release announcing a series of strategic capital governance actions that significantly enhance Go Health's financial flexibility and long-term positioning, as well as our results for the second quarter 2025. We have posted the release on the Go Health website under the Investor Relations tab. In the press release, we have listed certain risk factors that you should consider in conjunction with our forward-looking statements. We encourage you to consider the other risk ...